Response of the Authors.
作者信息
Bergamaschi Luca, Paolisso Pasquale, Angeli Francesco, Fabrizio Michele, Rinaldi Andrea, Foà Alberto, Pizzi Carmine
机构信息
Unit of Cardiology, Department of Experimental, Diagnostic and Specialty Medicine-DIMES, IRCCS. S. Orsola Hospital, University of Bologna, Bologna, Italy.
出版信息
Ann Noninvasive Electrocardiol. 2021 May;26(3):e12852. doi: 10.1111/anec.12852.
Abstract
摘要
相似文献
1
Response of the Authors.作者的回应。
Ann Noninvasive Electrocardiol. 2021 May;26(3):e12852. doi: 10.1111/anec.12852.
2
SARS-CoV-2 and electrocardiography: is electrocardiography a predictor of mortality?严重急性呼吸综合征冠状病毒2与心电图：心电图是死亡率的预测指标吗？
Europace. 2021 Jul 18;23(7):1150. doi: 10.1093/europace/euab075.
3
Comments on the value of ECG changes in risk stratification of COVID-19 patients.关于心电图变化在新冠病毒肺炎患者风险分层中的价值的评论
Ann Noninvasive Electrocardiol. 2021 May;26(3):e12841. doi: 10.1111/anec.12841. Epub 2021 Mar 19.
4
SARS-CoV-2: exposure to high external doses as determinants of higher viral loads and of increased risk for COVID-19. A systematic review of the literature.SARS-CoV-2：高外部剂量暴露作为 COVID-19 病毒载量更高和风险增加的决定因素。文献系统综述。
Epidemiol Prev. 2020 Sep-Dec;44(5-6 Suppl 2):152-159. doi: 10.19191/EP20.5-6.S2.114.
5
Occupational risks for SARS-CoV-2 infection: the Polish experience.职业暴露感染 SARS-CoV-2 的风险：波兰经验。
Int J Occup Med Environ Health. 2020 Oct 20;33(6):781-789. doi: 10.13075/ijomeh.1896.01663. Epub 2020 Jul 22.
6
The relationship between severe acute respiratory syndrome coronavirus 2 (SARS - COV - 2) pandemic and fragmented QRS.严重急性呼吸综合征冠状病毒2（SARS-CoV-2）大流行与碎裂QRS波之间的关系
J Electrocardiol. 2020 Sep-Oct;62:10-13. doi: 10.1016/j.jelectrocard.2020.07.009. Epub 2020 Jul 22.
7
SARS-CoV-2 and its relationship with the genitourinary tract: Implications for male reproductive health in the context of COVID-19 pandemic.SARS-CoV-2 及其与泌尿生殖系统的关系：COVID-19 大流行背景下对男性生殖健康的影响。
Andrology. 2021 Jan;9(1):73-79. doi: 10.1111/andr.12896. Epub 2020 Sep 30.
8
Medidas de prevención y control para SARS-CoV-2 (COVID-19) en cirugía.外科手术中针对SARS-CoV-2（新冠病毒）的预防和控制措施
Cir Cir. 2020;88(6):818-819. doi: 10.24875/CIRU.20000599.
9
Serial Testing for SARS-CoV-2 and Virus Whole Genome Sequencing Inform Infection Risk at Two Skilled Nursing Facilities with COVID-19 Outbreaks - Minnesota, April-June 2020.对两家发生 COVID-19 疫情的熟练护理机构进行的 SARS-CoV-2 连续检测和病毒全基因组测序有助于了解感染风险——明尼苏达州，2020 年 4 月至 6 月。
MMWR Morb Mortal Wkly Rep. 2020 Sep 18;69(37):1288-1295. doi: 10.15585/mmwr.mm6937a3.
10
Consensus summary report for CEPI/BC March 12-13, 2020 meeting: Assessment of risk of disease enhancement with COVID-19 vaccines.CEPI/BC 2020 年 3 月 12-13 日会议共识总结报告：评估 COVID-19 疫苗引起疾病增强的风险。
Vaccine. 2020 Jun 26;38(31):4783-4791. doi: 10.1016/j.vaccine.2020.05.064. Epub 2020 May 25.
本文引用的文献
1
Comments on the value of ECG changes in risk stratification of COVID-19 patients.关于心电图变化在新冠病毒肺炎患者风险分层中的价值的评论
Ann Noninvasive Electrocardiol. 2021 May;26(3):e12841. doi: 10.1111/anec.12841. Epub 2021 Mar 19.
2
The value of ECG changes in risk stratification of COVID-19 patients.心电图变化在 COVID-19 患者风险分层中的价值。
Ann Noninvasive Electrocardiol. 2021 May;26(3):e12815. doi: 10.1111/anec.12815. Epub 2021 Jan 29.
3
Safety of hydroxychloroquine and darunavir or lopinavir in COVID-19 infection.羟氯喹和达芦那韦或洛匹那韦治疗 COVID-19 感染的安全性。
J Antimicrob Chemother. 2021 Jan 19;76(2):482-486. doi: 10.1093/jac/dkaa441.
4
Arrhythmic safety of hydroxychloroquine in COVID-19 patients from different clinical settings.羟氯喹在不同临床环境下 COVID-19 患者中的心律失常安全性。
Europace. 2020 Dec 23;22(12):1855-1863. doi: 10.1093/europace/euaa216.
5
Preliminary Experience With Low Molecular Weight Heparin Strategy in COVID-19 Patients.新型冠状病毒肺炎患者低分子量肝素策略的初步经验
Front Pharmacol. 2020 Aug 6;11:1124. doi: 10.3389/fphar.2020.01124. eCollection 2020.
6
Electrocardiographic features of patients with COVID-19 pneumonia.新型冠状病毒肺炎患者的心电图特征。
Eur J Intern Med. 2020 Aug;78:101-106. doi: 10.1016/j.ejim.2020.06.015. Epub 2020 Jun 20.
7
Negative impact of hyperglycaemia on tocilizumab therapy in Covid-19 patients.高血糖对 COVID-19 患者托珠单抗治疗的负面影响。
Diabetes Metab. 2020 Oct;46(5):403-405. doi: 10.1016/j.diabet.2020.05.005. Epub 2020 May 21.
8
Remdesivir for the Treatment of Covid-19 - Final Report.瑞德西韦治疗 COVID-19 的疗效 - 最终报告。
N Engl J Med. 2020 Nov 5;383(19):1813-1826. doi: 10.1056/NEJMoa2007764. Epub 2020 Oct 8.
9
A Trial of Lopinavir-Ritonavir in Adults Hospitalized with Severe Covid-19.洛匹那韦-利托那韦治疗成人重症 COVID-19 患者的临床试验。
N Engl J Med. 2020 May 7;382(19):1787-1799. doi: 10.1056/NEJMoa2001282. Epub 2020 Mar 18.
Zotero 插件